DVT and PE (pulmonary embolism)- What is it? & the plastic surgery risks
Links shared publicly online about this topic.
- 859total visits
DVT and PE (pulmonary embolism)- What is it? & the plastic surgery risks
View full resource at laurengreenbergmd.com
Tags: Circulatory Disorders, Deep Venous Thrombosis, Thrombotic Event, Cosmetic Procedure, Plastic Surgery, Pulmonology, Surgery
Most Recently Shared on September 20, 2010 at 8:16 pm By:
DVT and PE (pulmonary embolism)- What is it? & the plastic surgery risks http://tinyurl.com/28sp9e8
What's In Your Stocking? Make Sure It's Not DVT
medicalnewstoday.com — “Deep vein thrombosis (DVT) is a blood clot in the deep veins in the legs. These clots can break loose and travel to the lungs, causing a potentially fatal pulmonary embolism (PE). Even when they d” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2011 at 10:07 am By:
What's In Your Stocking? Make Sure It's Not DVT http://t.co/Idc8gxMW #blood #hematology
Deep Venous Thrombosis and Thrombophlebitis: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Deep venous thrombosis (DVT) and its sequela, pulmonary embolism (PE), are the leading causes of preventable in-hospital mortality in the United States. Although PE itself is discussed in other articles, it occurs primarily as a complication ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 23, 2010 at 3:50 am By:
Deep venous thrombosis and thrombophlebitis can cause medical emergencies. Learn more about these conditions. http://bit.ly/9uaNXS
Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications
news-medical.net — “Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).” View full resource at news-medical.net
Most Recently Shared on February 4, 2010 at 6:51 am By:
Stroke News: Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications: Daiic... http://twurl.nl/k3j5mw
Rosuvastatin in the prevention of venous thromboembolism
blogs.theheart.org — “A landmark megatrial cuts the rate of DVT and pulmonary embolism by more than 40%, without any increased risk of bleeding. The JUPITER Trial releases its landmark findings in DVT and PE prevention.” View full resource at blogs.theheart.org
Most Recently Shared on May 29, 2009 at 4:01 pm By:
Rosuvastatin in the Prevention of Venous Thromboembolism: What are the implication of the JUPITER trial's landma.. http://bit.ly/Xf49m
Advertisement

